These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16567726)

  • 41. Differentiation of Parkinson's disease and progressive supranuclear palsy with magnetic resonance imaging: the first Brazilian experience.
    Barsottini OG; Ferraz HB; Maia AC; Silva CJ; Rocha AJ
    Parkinsonism Relat Disord; 2007 Oct; 13(7):389-93. PubMed ID: 17275393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis.
    Boeve BF
    Alzheimer Dis Assoc Disord; 2007; 21(4):S31-8. PubMed ID: 18090421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Corticobasal degeneration presenting with progressive spasticity.
    Hasselblatt M; Föllinger S; Steinbach P; Schwan A; Paulus W
    Neurology; 2007 Mar; 68(10):791-2. PubMed ID: 17339593
    [No Abstract]   [Full Text] [Related]  

  • 44. [Steele-Richardson-Olszewski syndrome].
    Pletz C
    Klin Monbl Augenheilkd; 2007 Dec; 224(12):939-42. PubMed ID: 18260059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive supranuclear palsy.
    Venmans A; Nijssen PC; Sluzewski M; van Rooij WJ
    JBR-BTR; 2009; 92(3):182-3. PubMed ID: 19670589
    [No Abstract]   [Full Text] [Related]  

  • 46. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Wszolek ZK; Slowinski J; Imamura A; Tsuboi Y; Broderick DF
    Neurology; 2006 Mar; 66(5):781; author reply 781. PubMed ID: 16534133
    [No Abstract]   [Full Text] [Related]  

  • 48. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.
    Rossor MN; Brown J
    J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):343. PubMed ID: 7673978
    [No Abstract]   [Full Text] [Related]  

  • 49. New candidate species most closely related to penguins.
    Watanabe M; Nikaido M; Tsuda TT; Kobayashi T; Mindell D; Cao Y; Okada N; Hasegawa M
    Gene; 2006 Aug; 378():65-73. PubMed ID: 16806742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pain in progressive supranuclear palsy.
    Schlesinger I; Klesier A; Yarnitsky D
    Clin Neuropharmacol; 2009; 32(3):163-4. PubMed ID: 19483485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autonomic dysfunction in patients with progressive supranuclear palsy.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Reichmann H; Berg D; Ziemssen T
    Mov Disord; 2008 Oct; 23(14):2083-9. PubMed ID: 18792126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editor's Note: The Beauty and Convenience of Simplicity: Will It Help Enlighten Our Understanding of Progressive Supranuclear Palsy?
    Obeso JA
    Mov Disord; 2019 Sep; 34(9):1283. PubMed ID: 31539463
    [No Abstract]   [Full Text] [Related]  

  • 54. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study.
    Kanazawa M; Shimohata T; Toyoshima Y; Tada M; Kakita A; Morita T; Ozawa T; Takahashi H; Nishizawa M
    Mov Disord; 2009 Jul; 24(9):1312-8. PubMed ID: 19412943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laryngeal dystonia causing upper airway obstruction in progressive supranuclear palsy.
    Panegyres PK; Hillman D; Dunne JW
    J Clin Neurosci; 2007 Apr; 14(4):380-1. PubMed ID: 16597502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Morphological magnetic resonance imaging: its value for the diagnosis of neurodegenerative diseases].
    Hahn U; Schwarz J; Gratz S; Kaiser JW; Jarnig M; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S15-8. PubMed ID: 18437637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Ashour R; Jankovic J
    Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progressive supranuclear palsy.
    Harv Womens Health Watch; 2006 Oct; 14(2):4-5. PubMed ID: 17167893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.